| All eyes | Eyes with at least one structural complications | Eyes with no structural complications | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
AC cell grade | AC cell grade | AC cell grade | ||||||||||
0 | 0.5+ | 1+ | 2+/ 3+/ 4+ | 0 | 0.5+ | 1+ | 2+/ 3+/ 4+ | 0 | 0.5+ | 1+ | 2+/ 3+/ 4+ | |
Baseline | ||||||||||||
 AC flare grade: no flare | 20 (66.7%) | 5 (31.3%) | 9 (17.0%) | 7 (18.9%) | 6 (46.2%) | 2 (25.0%) | 3 (10.3%) | 3 (12.0%) | 13 (81.3%) | 3 (37.5%) | 6 (25.0%) | 4 (33.3%) |
 AC flare grade: any flare | 10 (33.3%) | 11 (68.8%) | 44 (83.0%) | 30 (81.1%) | 7 (53.8%) | 6 (75.0%) | 26 (89.7%) | 22 (88.0%) | 3 (18.8%) | 5 (62.5%) | 18 (75.0%) | 8 (66.7%) |
3-months follow-up | ||||||||||||
 AC flare grade: no flare | 56 (83.6%) | 6 (30.0%) | 2 (14.3%) | 2 (16.7%) | 23 (82.1%) | 4 (26.7%) | 2 (18.2%) | 2 (22.2%) | 33 (84.6%) | 2 (40.0%) | 0 (0.0%) | 0 (0.0%) |
 AC flare grade: any flare | 11 (16.4%) | 14 (70.0%) | 12 (85.7%) | 10 (83.3%) | 5 (17.9%) | 11 (73.3%) | 9 (81.8%) | 7 (77.8%) | 6 (15.4%) | 3 (60.0%) | 3 (100.0%) | 3 (100.0%) |
6-months follow-up | ||||||||||||
 AC flare grade: no flare | 60 (87.0%) | 1 (12.5%) | 2 (33.3%) | 0 (0.0%) | 33 (82.5%) | 1 (16.7%) | 0 (0.0%) | 0 (0.0%) | 27 (93.1%) | 0 (0.0%) | 2 (66.7%) | 0 (0.0%) |
 AC flare grade: any flare | 9 (13.0%) | 7 (87.5%) | 4 (66.7%) | 4 (100.0%) | 7 (17.5%) | 5 (83.3%) | 3 (100.0%) | 4 (100.0%) | 2 (6.9%) | 2 (100.0%) | 1 (33.3%) | 0 (0.0%) |